Trials / Completed
CompletedNCT04331886
An Observational Study of Patients With Coronavirus Disease 2019
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 199 (actual)
- Sponsor
- Target PharmaSolutions, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
Detailed description
Data from up to 5,000 adult patients in the US will be captured from eligible patients enrolled following admission to the hospital. Participants will have de-identified medical records collected from hospital admission to discharge, including but not limited to critical care monitoring, details on mechanical ventilation, laboratory data, imaging reports, medications, and all procedures. Diagnosis and patient management will follow each hospital's standard of care and no specific treatments, procedures or laboratory tests will be dictated by enrollment in TARGET-COVID-19.
Conditions
Timeline
- Start date
- 2020-04-13
- Primary completion
- 2020-08-20
- Completion
- 2022-09-26
- First posted
- 2020-04-02
- Last updated
- 2025-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04331886. Inclusion in this directory is not an endorsement.